• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Holdings
© 2025 Longbridge|Disclaimer

Event Tracking

Dec29
Hengrui Medicine Subsidiary Obtains Clinical Trial Approval for HRS-6257
10:01
Dec28
Innovent's DaBerXin® Approved for Neoadjuvant Therapy in Colorectal Cancer
23:40
Innovent Biologics Receives Approval for Pre-surgical Treatment Drugs for Colon Cancer
23:30
China Biologic Completes Phase II Clinical Trials for Psoriasis Drug TQH3906
22:40
Hanson Pharma Signs License Agreement with Jiangsu Hengrui for SHR6508
12:11
Huahai Pharmaceutical and Shanghai Huahai's SHR-A1904 Injection Listed as Breakthrough Therapy
10:24